Epiq Partners, LLC Abb Vie Inc. Transaction History

Epiq Partners, LLC

$165 Million
Q3 2024

A detailed history of Epiq Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Epiq Partners, LLC holds 3,685 shares of ABBV stock, worth $647,012. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,685

Previous 3,685 -0.0%

Holding current value

$647,012

Previous $632,000 15.03%

% of portfolio

0.44%

Previous 0.45%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$154.79 - $180.76 $10,525 - $12,291	-68 Reduced 1.81%	3,685 $632,000
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $2.21 Million - $2.52 Million	-13,827 Reduced 78.65%	3,753 $683,000
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $101,824 - $114,677	-740 Reduced 4.04%	17,580 $2.72 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $118,227 - $136,865	-885 Reduced 4.61%	18,320 $2.73 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $7,950 - $9,894	-60 Reduced 0.31%	19,205 $2.59 Million
Q1 2023 Apr 12, 2023	BUY	$144.61 - $166.54 $5,784 - $6,661	40 Added 0.21%	19,265 $3.07 Million
Q4 2022 Jan 06, 2023	SELL	$138.31 - $165.87 $248,958 - $298,566	-1,800 Reduced 8.56%	19,225 $0
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $130,854 - $150,081	975 Added 4.86%	21,025 $2.82 Million
Q2 2022 Jul 07, 2022	BUY	$137.62 - $174.96 $44,038 - $55,987	320 Added 1.62%	20,050 $3.07 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $237,563 - $294,750	1,800 Added 10.04%	19,730 $3.2 Million
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $471,187 - $596,188	-4,386 Reduced 19.65%	17,930 $2.43 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $409,640 - $465,003	3,850 Added 20.85%	22,316 $2.41 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $73,226 - $81,578	696 Added 3.92%	18,466 $2.08 Million
Q1 2021 Apr 16, 2021	BUY	$102.3 - $112.62 $140,662 - $154,852	1,375 Added 8.39%	17,770 $1.92 Million
Q4 2020 Jan 11, 2021	BUY	$80.49 - $108.67 $268,434 - $362,414	3,335 Added 25.54%	16,395 $1.76 Million
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $60,137 - $70,581	-700 Reduced 5.09%	13,060 $1.08 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $14,674 - $19,636	-200 Reduced 1.43%	13,760 $1.35 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $30,637 - $46,450	475 Added 3.52%	13,960 $1.06 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $972,673 - $1.22 Million	13,485 New	13,485 $1.19 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Partners, LLC with notifications on news.

Account

Epiq Partners, LLC Abb Vie Inc. Transaction History